cathepsin K inhibitors (Bayer)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Namecathepsin K inhibitors (Bayer)

Drug Alias NameN/A

ClassificationSmall molecules > Peptidomimetic

Mechanisms of ActionCathepsin K inhibitors

TargetsCathepsin K

Therapy Area/IndicationsOsteoporosisBone Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsOsteoporosisBone Diseases

ATC CodeN/A